|[August 25, 2014]
SHAREHOLDER ALERT: Brower Piven Announces The Investigation Of InterMune, Inc. In Connection With The Proposed Sale Of The Company To Roche Holdings, Inc.
STEVENSON, Md. --(Business Wire)--
The securities litigation law firm of Brower Piven, A Professional
Corporation, has commenced an investigation into possible breaches of
fiduciary duty and other violations of state law by the Board of
Directors of InterMune, Inc. ("InterMune" or the "Company") (NASDAQ:
ITMN) relating to the proposed buyout of the Company by Roche Holdings,
On August 24, 2014, InterMune and Roche announced the signing of a
definitive merger agreement pursuant to which Roche will acquire
InterMune in a transaction valued at approximately $8.3 billion. Under
the terms of the transaction, InterMune shareholders are anticipated to
receive $74.00 in cash for each share of InterMune comon stock they own.
The firm's investigation seeks to determine, among other things, whether
the Company's Board of Directors breached their fiduciary duties by
failing to maximize shareholder value before agreeing to enter into the
transaction, and whether Roche is underpaying for InterMune shares.
If you currently own common stock of InterMune and would like to learn
more about the investigation being conducted by Brower Piven, without
cost or obligation to you, please visit our website at http://www.browerpiven.com/currentinvestigations.html.
You may also request more information by contacting Brower Piven either
by email at email@example.com
or by telephone at (410) 415-6616.
Attorneys at Brower Piven have extensive experience in litigating
securities and other class action cases and have been advocating for the
rights of shareholders since the 1980s.
[ Back To TMCnet.com's Homepage ]